Analysed RENOVORX INC (RNXT:NASDAQ) News Sources
RenovoRx Inc (RNXT) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Expansion ...
13-08-2026
yahoo.com
RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer
25-08-2026
yahoo.com
RenovoRx H.C. Wainwright Presentation to Highlight RenovoCath Growth and Phase III TIGeR-PaC Timeline
02-09-2026
advfn.com
RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial
07-10-2026
yahoo.com
RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026
22-10-2026
yahoo.com
What is the current price of RENOVORX INC (RNXT:NASDAQ)?
The current price of RENOVORX INC (RNXT:NASDAQ) is $1.33.
RENOVORX INC (RNXT:NASDAQ) absolute price change since previous trading day?
The absolute price change of RENOVORX INC (RNXT:NASDAQ) since the previous trading day is $-0.16.
RENOVORX INC (RNXT:NASDAQ) percentage price change since previous trading day?
The percentage price change of RENOVORX INC (RNXT:NASDAQ) since the previous trading day is -10.7383%.
What is the most recent average sentiment score for RENOVORX INC (RNXT:NASDAQ)?
The most recent average sentiment score for RENOVORX INC (RNXT:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for RENOVORX INC (RNXT:NASDAQ)?
The most recent sentiment for RENOVORX INC (RNXT:NASDAQ) is .
SEC-8K** Filing Available For RENOVORX INC (RNXT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.